Table III.
Results of meta-analysis.
| Outcomes | No. of studies | No. of patients | HR/OR/RR (95% CI) | P-value | Heterogeneity I2 (%) | Publication bias P-value |
|---|---|---|---|---|---|---|
| LNM | 6 | 740 | 0.53 (0.46–0.61) | <1×10−4 | 93.8 | 0.145 |
| T | 7 | 1,031 | 1.07 (0.94–1.22) | 0.23 | 79.0 | 0.527 |
| OS (DR) | 8 | 768 | 0.59 (0.47–0.75) | <1×10−4 | 0.0 | 0.447 |
| OS (UR) | 5 | 768 | 1.76 (1.31–2.35) | <1×10−4 | 60.2 | 0.447 |
CI, confidence interval; HR, hazard ratio; OR, odds ratio; RR, relative risk; LNM, lymph node metastasis; T, tumor state of cancers; OS, overall survival; DR, downregulation; UR, upregulation.